Marshall Wace’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$753K Buy
+18,692
New +$699K ﹤0.01% 2272
2025
Q3
Sell
-46,200
Closed -$3.39M 2963
2025
Q2
$3.39M Buy
46,200
+41,040
+795% +$2.98M ﹤0.01% 1320
2025
Q1
$589K Buy
+5,160
New +$314K ﹤0.01% 2016
2024
Q3
Sell
-20,200
Closed -$656K 2572
2024
Q2
$656K Sell
20,200
-78,299
-79% -$2.14M ﹤0.01% 1862
2024
Q1
$2.48M Buy
+98,499
New +$2.33M ﹤0.01% 1257
2023
Q4
Sell
-19,042
Closed -$519K 2241
2023
Q3
$519K Sell
19,042
-168,584
-90% -$4.88M ﹤0.01% 1711
2023
Q2
$4.17M Buy
187,626
+65,500
+54% +$1.51M 0.01% 1103
2023
Q1
$2.65M Buy
+122,126
New +$2.68M 0.01% 1298
2022
Q4
Sell
-29,372
Closed -$753K 3016
2022
Q3
$753K Sell
29,372
-25,596
-47% -$685K ﹤0.01% 2546
2022
Q2
$1.31M Buy
+54,968
New +$1.2M ﹤0.01% 2285
2021
Q3
Sell
-9,941
Closed -$219K 3089
2021
Q2
$219K Sell
9,941
-36,337
-79% -$809K ﹤0.01% 2420
2021
Q1
$1.1M Sell
46,278
-205,122
-82% -$5.48M 0.01% 1611
2020
Q4
$6.58M Sell
251,400
-298,682
-54% -$6.29M 0.04% 481
2020
Q3
$9.58M Buy
+550,082
New +$8.77M 0.07% 313
2020
Q2
Sell
-538,555
Closed -$6.4M 1603
2020
Q1
$6.4M Buy
538,555
+484,178
+890% +$5.99M 0.06% 309
2019
Q4
$658K Sell
54,377
-235,809
-81% -$3.28M ﹤0.01% 1084
2019
Q3
$4.1M Sell
290,186
-13,318
-4% -$164K 0.03% 558
2019
Q2
$3.38M Buy
303,504
+50,523
+20% +$563K 0.03% 610
2019
Q1
$2.97M Sell
252,981
-320,855
-56% -$3.99M 0.03% 633
2018
Q4
$7.67M Buy
573,836
+456,584
+389% +$6.03M 0.08% 318
2018
Q3
$1.64M Buy
+117,252
New +$1.64M 0.01% 717

Other funds holding CORT